Livforsakringsbolaget Skandia Omsesidigt Has $172,000 Position in Aflac Incorporated (NYSE:AFL)

Livforsakringsbolaget Skandia Omsesidigt raised its stake in shares of Aflac Incorporated (NYSE:AFL) by 31.2% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 2,088 shares of the financial services provider’s stock after buying an additional 497 shares during the quarter. Livforsakringsbolaget Skandia Omsesidigt’s holdings in Aflac were worth $172,000 at the end of the most recent reporting period.

Other institutional investors also recently modified their holdings of the company. Daiwa Securities Group Inc. lifted its holdings in shares of Aflac by 6.3% during the 4th quarter. Daiwa Securities Group Inc. now owns 50,190 shares of the financial services provider’s stock valued at $4,141,000 after purchasing an additional 2,992 shares in the last quarter. Scissortail Wealth Management LLC bought a new position in shares of Aflac during the 4th quarter valued at about $646,000. Tyche Wealth Partners LLC bought a new position in shares of Aflac during the 4th quarter valued at about $1,501,000. SVB Wealth LLC lifted its holdings in shares of Aflac by 7.6% during the 4th quarter. SVB Wealth LLC now owns 11,156 shares of the financial services provider’s stock valued at $920,000 after purchasing an additional 786 shares in the last quarter. Finally, Flputnam Investment Management Co. lifted its holdings in shares of Aflac by 0.5% during the 4th quarter. Flputnam Investment Management Co. now owns 25,031 shares of the financial services provider’s stock valued at $2,065,000 after purchasing an additional 122 shares in the last quarter. 67.44% of the stock is currently owned by institutional investors and hedge funds.

Aflac Stock Up 0.9 %

AFL opened at $80.98 on Friday. Aflac Incorporated has a 1-year low of $64.10 and a 1-year high of $86.26. The stock’s fifty day simple moving average is $82.11 and its 200 day simple moving average is $81.46. The company has a current ratio of 0.06, a quick ratio of 0.06 and a debt-to-equity ratio of 0.33. The stock has a market cap of $46.60 billion, a PE ratio of 10.45, a price-to-earnings-growth ratio of 2.21 and a beta of 0.91.

Aflac (NYSE:AFL) last posted its quarterly earnings results on Thursday, February 1st. The financial services provider reported $1.25 earnings per share for the quarter, missing analysts’ consensus estimates of $1.47 by ($0.22). Aflac had a net margin of 24.92% and a return on equity of 17.59%. The business had revenue of $3.78 billion during the quarter, compared to the consensus estimate of $4.44 billion. During the same quarter last year, the company posted $1.29 EPS. As a group, research analysts expect that Aflac Incorporated will post 6.41 earnings per share for the current year.

Insider Activity at Aflac

In related news, Director Thomas J. Kenny sold 5,000 shares of the stock in a transaction on Wednesday, March 20th. The stock was sold at an average price of $84.62, for a total value of $423,100.00. Following the sale, the director now owns 17,920 shares in the company, valued at approximately $1,516,390.40. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. In other Aflac news, Director Thomas J. Kenny sold 5,000 shares of the stock in a transaction on Wednesday, March 20th. The stock was sold at an average price of $84.62, for a total transaction of $423,100.00. Following the transaction, the director now owns 17,920 shares in the company, valued at approximately $1,516,390.40. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, SVP Albert Riggieri sold 8,000 shares of the stock in a transaction on Thursday, March 14th. The stock was sold at an average price of $83.34, for a total value of $666,720.00. Following the transaction, the senior vice president now owns 32,825 shares in the company, valued at approximately $2,735,635.50. The disclosure for this sale can be found here. In the last quarter, insiders have sold 46,493 shares of company stock worth $3,765,706. Company insiders own 0.90% of the company’s stock.

Analyst Ratings Changes

A number of equities analysts have weighed in on AFL shares. Evercore ISI downgraded Aflac from an “in-line” rating to an “underperform” rating and upped their price target for the stock from $76.00 to $78.00 in a research report on Thursday, January 4th. Morgan Stanley upped their price target on Aflac from $80.00 to $84.00 and gave the stock an “equal weight” rating in a research report on Monday. Keefe, Bruyette & Woods upped their price target on Aflac from $83.00 to $87.00 and gave the stock a “market perform” rating in a research report on Wednesday, April 10th. UBS Group upped their price target on Aflac from $80.00 to $84.00 and gave the stock a “neutral” rating in a research report on Wednesday, January 10th. Finally, The Goldman Sachs Group upped their price target on Aflac from $61.00 to $75.00 and gave the stock a “sell” rating in a research report on Tuesday, January 9th. Three investment analysts have rated the stock with a sell rating, eight have issued a hold rating and three have issued a buy rating to the company. Based on data from MarketBeat, the company has an average rating of “Hold” and an average price target of $82.15.

Aflac Company Profile

Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.